🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we received a grant to conduct a study to test a urine assay in patients presenting with #nonvisible #hematuria. RCT of #cystoscopy versus urine assay +/- cysto depending on test result. Goal = reduce number of negative cysto’s cc Joep J. de Jong Tahlita Zuiverloon MD PhD

One #bladdercancer icon honoring another - read Festschrift from Ellen Zwarthoff (and others) congratulating Maggie Knowles on a remarkable career in bladder cancer research. University of Leeds Science and Innovation at Cancer Research UK Yorkshire Cancer Research Bladder Cancer rb.gy/apolpl

Het EUCRG van het Blaaskankercentrum is een samenwerking gestart met Amerikaanse partners om nieuwe therapieën te vinden voor blaaskankerpatiënten die worden behandeld met BCG. oncologie.nu/nieuws/erasmus…

At the Erasmus MC Urothelial Cancer Research Group we've shown that pathological T1 substaging can improve risk stratification of BCG treated patients pubmed.ncbi.nlm.nih.gov/33191862/ Christiaan de Jong Leven met blaas- of nierkanker Joep J. de Jong @joostboormans Blaaskankercentrum Tahlita Zuiverloon MD PhD Ellen Zwarthoff

A very insightful review by Mathijs Scholtes on metabolic reprogramming to improve immunotherapy in bladder cancer pubmed.ncbi.nlm.nih.gov/33466735 Christiaan de Jong Leven met blaas- of nierkanker Blaaskankercentrum Tahlita Zuiverloon MD PhD Dan Theodorescu

On Jan 26, took place the 1st on-line networking training session of CLARIFY. Supervisors, co-supervisors and #ESRs introduced themselves as an introduction to partner’s expertise and disciplines. This training was hosted by CVBLab. #AI #CloudComputing #digitalpathology

3 urological cancers remain also this year among the top 10 most common cancers in Europe: Prostate, Bladder and Kidney. Every person matters. Every action counts. That is why we constantly update the EAUguidelines. ▶️ uroweb.org/individual-gui… #worldcancerday #eauguidelines

Good news!🗯️We will launch a #blog on our webpage: 𝐅𝐑𝐎𝐌 𝐂𝐋𝐀𝐑𝐈𝐅𝐘 𝐓𝐎 𝐓𝐇𝐄 𝗪𝐎𝐑𝐋𝐃. There, our researchers will share their motivations, aspirations and achievements. First post➡️next week. clarify-project.eu #AI #CloudComputing #DigitalPathology

A great team! Visit Researchers section to get to know them! clarify-project.eu/#researchers #researchers #ArtificialIntelligence #AI #CloudComputing #digitalpathology #cancerresearch #MSCA #itn #H2020

chris bangma Blaaskankercentrum

📢First blog post in our webpage! Saul, ESR5 from Universitetet i Stavanger talkes about him and his venture in #CLARIFY project. clarify-project.eu/from-clarify-t… Each week we will know more about one of our #ESRs. Follow the #CLARIFY's blog.

ESR7 participated in a MATLAB seminar to learn more about using #MATLAB libraries within #Python.

Starting today

The M1 aminopeptidase NPEPPS is a novel regulator of cisplatin sensitivity biorxiv.org/cgi/content/sh… #bioRxiv

Great summary slide from Sima Porten's talk on emerging options for patients with BCG Unresponsive non-muscle-invasive #Bladdercancer

NPEPPS key to cisplatin resistance in bladder cancer?! Dan Theodorescu @mpscholtes Tahlita Zuiverloon MD PhD Teemu Daniel Laajala Ashish M. Kamat, MD, MBBS Peter Black @joostboormans Lars Dyrskjøt Dr. Bishoy M. Faltas IBCN Bart Kiemeney European Urology @noahhan Tom Powles David McConkey BCAN NCT Chapter biorxiv.org/content/10.110…

Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical Bacillus Calmette-Guerin medrxiv.org/cgi/content/sh… #medRxiv

Yesterday NWO Nieuws announced the 2021 ZonMw #Vici laureates, supporting 6 promising medical #research talents. While we are genuinely happy for them, the utter lack of #diversity among the laureates, who were all white Dutch males, left us with a very bitter aftertaste. (1/7)